These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1864485)

  • 1. Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse.
    Thivolet CH; Goillot E; Bedossa P; Durand A; Bonnard M; Orgiazzi J
    Diabetologia; 1991 May; 34(5):314-9. PubMed ID: 1864485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.
    Miller BJ; Appel MC; O'Neil JJ; Wicker LS
    J Immunol; 1988 Jan; 140(1):52-8. PubMed ID: 3275717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
    Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
    Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.
    Wicker LS; Miller BJ; Mullen Y
    Diabetes; 1986 Aug; 35(8):855-60. PubMed ID: 3525284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I; Fabien N; Thivolet C
    Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse.
    Reddy S; Bibby NJ; Elliott RB
    Diabetologia; 1988 May; 31(5):322-8. PubMed ID: 3294069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
    Saï P; Senecat O; Martignat L; Gouin E
    Clin Exp Immunol; 1994 Jul; 97(1):138-45. PubMed ID: 8033411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes.
    Reich EP; Scaringe D; Yagi J; Sherwin RS; Janeway CA
    Diabetes; 1989 Dec; 38(12):1647-51. PubMed ID: 2684716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats.
    Gottlieb PA; Handler ES; Appel MC; Greiner DL; Mordes JP; Rossini AA
    Diabetologia; 1991 May; 34(5):296-300. PubMed ID: 1864483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy.
    Atkinson MA; Maclaren NK; Luchetta R
    Diabetes; 1990 Aug; 39(8):933-7. PubMed ID: 2197139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclosporin on autoimmune diabetes induced in mice by streptozotocin: beta cell-toxicity and rebound of insulitis after cessation of treatment.
    Sai P; Maugendre D; Loreal O; Maurel C; Pogu S
    Diabete Metab; 1988; 14(4):455-62. PubMed ID: 3066654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes.
    Bergerot I; Fabien N; Maguer V; Thivolet C
    Clin Exp Immunol; 1995 Nov; 102(2):335-40. PubMed ID: 7586687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.
    Elias D; Markovits D; Reshef T; van der Zee R; Cohen IR
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1576-80. PubMed ID: 2406723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of insulin-dependent diabetes mellitus in non-obese diabetic mice: the role of CD4+ and CD8+ T cells.
    Varey AM; Hutchings P; O'Reilly L; Hussell T; Waldmann H; Simpson E; Cooke A
    Biochem Soc Trans; 1991 Feb; 19(1):187-91. PubMed ID: 1903736
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
    Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
    Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of Ly2+ T cells in beta cell destruction.
    Hutchings PR; Simpson E; O'Reilly LA; Lund T; Waldmann H; Cooke A
    J Autoimmun; 1990 Apr; 3 Suppl 1():101-9. PubMed ID: 2187454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction.
    Bedossa P; Bendelac A; Bach JF; Carnaud C
    Eur J Immunol; 1989 Oct; 19(10):1947-51. PubMed ID: 2684673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors.
    Kuttler B; Dunger A; Volk HD; Diamantstein T; Hahn HJ
    Diabetologia; 1991 Feb; 34(2):74-7. PubMed ID: 2065851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.